Ginsenoside Rk1
CAS No. 494753-69-4
Ginsenoside Rk1( —— )
Catalog No. M20267 CAS No. 494753-69-4
Ginsenoside Rk1 is a component created by processing the ginseng plant at high temperatures. Ginsenoside Rk1 has an anti-inflammatory effect suppresses the activation of Jak2/Stat3 signaling pathway and NF-κB. It also has an anti-tumor effect.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 89 | In Stock |
|
| 100MG | Get Quote | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameGinsenoside Rk1
-
NoteResearch use only, not for human use.
-
Brief DescriptionGinsenoside Rk1 is a component created by processing the ginseng plant at high temperatures. Ginsenoside Rk1 has an anti-inflammatory effect suppresses the activation of Jak2/Stat3 signaling pathway and NF-κB. It also has an anti-tumor effect.
-
DescriptionGinsenoside Rk1 is a component created by processing the ginseng plant at high temperatures. Ginsenoside Rk1 has an anti-inflammatory effect suppresses the activation of Jak2/Stat3 signaling pathway and NF-κB. It also has an anti-tumor effect.
-
In VitroGinsenoside Rk1 (0-40 μM; 6 hours) inhibits MCP-1 and TNF-α mRNA induced by lipopolysaccharide (LPS), expression of IL-1β is inhibited at 40 μM.Ginsenoside Rk1 (0-40 μM; 24 hours) inhibits phosphorylation of JAK2 and STAT3 (Tyr705 and Ser727) in LPS-induced RAW264.7 cells in a dose-dependent manner.Ginsenoside Rk1 (0-160 μM; 48 hours) results in cell viability significant decrease 75.52 ± 2.51% (40 μM), 52.72 ± 2.54% (80 μM), 17.41 ± 2.94% (120 μM)and 12.63 ± 3.24% (160 μM) compared with control.Ginsenoside Rk1 (0-120 μM; 24 hours) increases G0/G1 phase proportion accompanied with S and G2/M phase proportion decrease in MDA-MB-231 cells.Ginsenoside Rk1 (0-120 μM; 24 hours) promotes the percentage of apoptotic cells in a dose-dependent manner, exhibits to reduction of cell number with nucleus fragmentation, condensation and apoptotic body formation. RT-PCR Cell Line:RAW264.7 cells Concentration:10 μM, 20 μM, 40 μM Incubation Time:6 hours Result: Inhibited JAK2-dependent STAT3 activation in LPS-activated RAW264.7 cells.Western Blot Analysis Cell Line:RAW264.7 cells Concentration:10 μM, 20 μM, 40 μM Incubation Time:6 hours Result:Inhibited JAK2-dependent STAT3 activation in LPS-activated RAW264.7 cells Cell Viability Assay Cell Line:MDA-MB-231 cells Concentration:0 μM, 40 μM, 80 μM, 120 μM Incubation Time:48 hours Result:Inhibited MDA-MB-231 cells proliferation in a dose- and time-dependent manner.Cell Cycle Analysis Cell Line:MDA-MB-231 cells Concentration:0 μM, 40 μM, 80 μM, 120 μM Incubation Time:24 hours Result:Induced G0/G1 phase arrest.Apoptosis Analysis Cell Line:MDA-MB-231 cells Concentration:0 μM, 40 μM, 80 μM, 120 μM Incubation Time:24 hours Result:Induced apoptosis in MDA-MB-231 cells.
-
In Vivo——
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
RecptorOthers
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number494753-69-4
-
Formula Weight767.01
-
Molecular FormulaC42H70O12
-
Purity>98% (HPLC)
-
SolubilityDMSO: 90 mg/mL (117.34 mM)
-
SMILES[H][C@@]12[C@H](CC[C@@]1(C)[C@]1(C)CC[C@@]3([H])C(C)(C)[C@H](CC[C@]3(C)[C@@]1([H])C[C@H]2O)O[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O)C(=C)CC\C=C(/C)C
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Kim JS et al. Induction of apoptosis by ginsenoside Rk1 in SK-MEL-2-human melanoma. Arch Pharm Res. 2012 Mar;35(4):717-22.
molnova catalog
related products
-
MitoBloCK-10
MitoBloCK-10 inhibits Tim44 binding to the precursor and to Hsp70.MitoBloCK-10 is the first small molecule modulator to attenuate protein-associated motor (PAM) complex activity.
-
TUG-469
TUG-469 is an effective free fatty acid 1 receptor agonist.
-
Dehydrojuncusol
Dehydrojuncusol, a new inhibitor of hepatitis C virus RNA replication, it inhibits infection of different HCV genotypes by targeting the NS5A protein and is active against resistant HCV variants frequently found in patients with treatment failure.
Cart
sales@molnova.com